http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0386882-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
filingDate 1990-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60dca34ecb048cf7dea1353865109e99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4a633e0af411f4cf4160274ddb7780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97e30806cfc8db427a7689d9941c703e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e906b873b1dee3b550f8ea1841e32208
publicationDate 1994-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0386882-B1
titleOfInvention Packaging defective HIV provirus, cell lines, and uses thereof
abstract A packaging defective HIV vector is disclosed. This vector can be used to establish HIV packaging defective cell lines. These cell lines can be used in developing a vaccine, HIV antibodies and as part of a system for gene transfer.
priorityDate 1989-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020

Total number of triples: 31.